Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) EBT Margin (2022 - 2025)

Historic EBT Margin for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 21909.5%.

  • HCW Biologics' EBT Margin fell 209917200.0% to 21909.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 3019.13%, marking a year-over-year decrease of 19473400.0%. This contributed to the annual value of 1173.09% for FY2024, which is 2581700.0% down from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' EBT Margin is 21909.5%, which was down 209917200.0% from 56378.49% recorded in Q2 2025.
  • HCW Biologics' EBT Margin's 5-year high stood at 60.33% during Q1 2022, with a 5-year trough of 56378.49% in Q2 2025.
  • Over the past 4 years, HCW Biologics' median EBT Margin value was 813.2% (recorded in 2023), while the average stood at 9582.42%.
  • As far as peak fluctuations go, HCW Biologics' EBT Margin surged by 123569200bps in 2024, and later plummeted by -539068800bps in 2025.
  • Over the past 4 years, HCW Biologics' EBT Margin (Quarter) stood at 429.49% in 2022, then crashed by -89bps to 813.2% in 2023, then decreased by -6bps to 863.18% in 2024, then crashed by -2438bps to 21909.5% in 2025.
  • Its EBT Margin was 21909.5% in Q3 2025, compared to 56378.49% in Q2 2025 and 43862.27% in Q1 2025.